The present studies were undertaken to determine whether the interleukin 4 binding proteins (IL4BPs) previously identified in the biological fluids of mice are soluble forms of IL4Rs . We also studied the binding properties of IL4BPs in order to gain insight into their physiological role in vivo . Affinity-purified IL4BPs and recombinant soluble IL4Rs generated similar onedimensional (Cleveland) peptide maps after digestion with either Staphylococcus aureus V8 protease or trypsin, indicating structural similarities . Furthermore, a rat mAb directed against the murine IL4Rs immunoprecipitated the IL4BPs and completely inhibited binding of 125 1-IL4 to a purified preparation of IL4BPs. Taken together these data indicate that the IL4BPs are soluble IL4Rs. At 4°C the IL4BPs competitively inhibited the binding of IL-4 to membrane IL4Rs but their ability to prevent binding of IL4 to cells at 37°C, at the same concentrations, was significantly reduced. Kinetic binding studies of soluble IL4BPs vs. membrane IL4Rs disclosed important differences in their rates of dissociation from IL-4. Whereas dissociation at 4°C was slow for both, dissociation of 114 from ILBPs at 37°C was considerably faster (t 1i2 of 2 min) than dissociation of IL4 from membrane IL4Rs (t i /2 of -69 min). Temperature-dependent changes in dissociation kinetics were reversible, and could not be accounted for by either inactivation of the IL4BPs at 37°C or receptor internalization . Additional experiments also demonstrated that when IL4BPs bind to IL4 at 37°C, the IL4/IL4BPs complex can rapidly dissociate, allowing IL-4 to bind to membrane IL4Rs. In addition, binding of 114 by the IL4BPs protects IIA from proteolytic degradation . Taken together, these results suggest that the IL4BPs are naturally occurring forms of soluble II,r4Rs and that some of their properties (fast dissociation kinetics and protection of 1174 from proteolysis) are consistent with a potential role as carrier proteins for IL-4 in the circulation .
Summary
The present studies were undertaken to determine whether the interleukin 4 binding proteins (IL4BPs) previously identified in the biological fluids of mice are soluble forms of IL4Rs . We also studied the binding properties of IL4BPs in order to gain insight into their physiological role in vivo . Affinity-purified IL4BPs and recombinant soluble IL4Rs generated similar onedimensional (Cleveland) peptide maps after digestion with either Staphylococcus aureus V8 protease or trypsin, indicating structural similarities . Furthermore, a rat mAb directed against the murine IL4Rs immunoprecipitated the IL4BPs and completely inhibited binding of 125 1-IL4 to a purified preparation of IL4BPs. Taken together these data indicate that the IL4BPs are soluble IL4Rs. At 4°C the IL4BPs competitively inhibited the binding of IL-4 to membrane IL4Rs but their ability to prevent binding of IL4 to cells at 37°C, at the same concentrations, was significantly reduced. Kinetic binding studies of soluble IL4BPs vs. membrane IL4Rs disclosed important differences in their rates of dissociation from IL-4. Whereas dissociation at 4°C was slow for both, dissociation of 114 from ILBPs at 37°C was considerably faster (t 1i2 of 2 min) than dissociation of IL4 from membrane IL4Rs (t i /2 of -69 min). Temperature-dependent changes in dissociation kinetics were reversible, and could not be accounted for by either inactivation of the IL4BPs at 37°C or receptor internalization . Additional experiments also demonstrated that when IL4BPs bind to IL4 at 37°C, the IL4/IL4BPs complex can rapidly dissociate, allowing IL-4 to bind to membrane IL4Rs. In addition, binding of 114 by the IL4BPs protects IIA from proteolytic degradation . Taken together, these results suggest that the IL4BPs are naturally occurring forms of soluble II,r4Rs and that some of their properties (fast dissociation kinetics and protection of 1174 from proteolysis) are consistent with a potential role as carrier proteins for IL-4 in the circulation .
Anumber of hormone and cytokine receptors exist in both membrane-bound and soluble forms (e.g. insulin-like growth factor and growth hormone receptors, as well as receptors for IIr2, IL4,1176, and TNF . Soluble cytokine receptors usually represent truncated forms of the membranebound molecules, lacking the transmembrane and intracytoplasmic domains but retaining the ligand-binding extracytoplasmic domain (5, 9, 10, 12, 13) . The roles played by soluble cytokine receptors in vivo are unclear. Possible functions include: (a) inhibition of cytokine activity in biological fluids (5, 9-11, 14, 15) , thus confining the activity of cytokines to their site of secretion; (b) signaling, by interacting with receptor-associated molecules on the membranes of target cells (e.g., IL6R) (16) ; and (c) transport of cytokines in the circulation, thus protecting their respective ligands from degradation and/or secretion, or increasing their half life in the circulation until they are delivered to target cells at distant anatomical sites (17) .
Recently, we described the presence of IL-4 binding proteins (IL4BPs) 1 in normal mouse serum and ascitic fluid (15) . IL4BPs bind IL-4 with high affinity and inhibit the activity of 114 in vitro (15) . Mosley, et al . (9) have described cDNAs encoding both the full length IL-4R molecules and secreted, truncated forms of IL4Rs . COS-7 cells transfected with cDNA clones encoding the latter, secreted a soluble form of the IL4R that retained its ligand-binding capacity and, inhibited both the binding and activity of IL4. The purpose of the present study was to determine whether IL4BPs are related to soluble IL4Rs (slIr4R) and to then investigate the binding properties of soluble IL4BPs in order to gain insight into their potential functions in vivo as IL-4-inhibitors or as IL-4-carrier proteins. Based on onedimensional peptide maps and reactivity with a mAb directed against the murine IL4Rs, the IL4BPs purified from ascitic fluid are structurally and immunologically related to sIL4Rs and thus are likely to be their naturally-occurring form. Ki-netic binding studies utilizing membrane IIr4Rs vs. soluble IIr4BPs indicate significant differences in their dissociation kinetics at 37°C : dissociation of IL4 from soluble IIr4BPs is 30-40-fold faster than that from membrane IIr4Rs . In addition, kinetic and equilibrium dissociation constants (Kd) suggest a decreased affinity of soluble IIr4BPs with increased temperature (4°C vs. 37°C) . Accordingly, IIr4BPs compete less effectively with membrane IIL4Rs for the binding of IL4 at 37°C. In a two-step incubation experiment, 125 1_114 that was previously bound by IIr4BPs could dissociate and bind to membrane IIr4Rs on HT-2 cells at 37°C but not at 4°C. Finally, binding of IIr4 by the soluble IIr4BPs resulted in acquisition of resistance of IIr4 to proteolytic degradation . Taken together, these results suggest that soluble IIr4BPs may play a role as carrier proteins for IIr4 in vivo.
Materials and Methods
Cells, Antibodies, and Reagents. The 11,2/114-responsive T cell line, HT-2 (18), was maintained in RPMI-1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% heatinactivated FCS (Hyclone Laboratories, Logan, UT), 100U/ml penicillin, 100 ug/ml streptomycin, 10 j ug/ml gentamicin, 2 mM L-glutamine, 50 wM 2-ME, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids and 10 U/ml recombinant human 11,2 (IL2 ; Amgen, Thousand Oaks, CA) as described (19) . The rat anti-mouse 114 antibody, 11BIl (20) , was obtained by growing the 11B11 hybridoma in a VLS Cell Culture System (Amicon, Beverley, MA). The final concentrate contained >3 mg/ml of the 11B11 antibody at >90% purity, as determined by a rat Ig-specific RIA and SDS-PAGE, respectively. A rat mAb directed against the murine IL4Rs was purchased from Genzyme (Cambridge, MA). This antibody inhibits the binding of IL4 to both membrane and soluble IIr4Rs (21) . Recombinant murine 11,4 was a generous gift from Dr. K. Grabstein (Immunex Corp., Seattle, WA) and recombinant murine soluble IIAR (9, 22) was kindly provided by Dr. Maureen Howard (DNAX, Palo Alto, CA). Staphylococcus aureus strain V8 protease (type XVII), trypsin coupled to polyacrylamide beads and hydroxyapatite (type I) were purchased from Sigma Chemical Co . (St. Louis, MO); Affigel-10 was obtained from Bio Rad (Richmond, CA).
Purification of IL4BPs. Murine ascitic fluid was chosen as the source of IIr4BPs. IIr4BPs are constitutively present in the biological fluids of normal mice, including serum and urine, but their concentration in ascitic fluid is twice that found in normal serum (15) . In addition, larger volumes can be obtained . Previous estimates based on I14-binding activity and assuming an average mol wt of 40 kD, suggested an approximate concentration of IIABPs in murine ascitic fluid of 50 ng/ml (1 .25 x 10' M) . Ascites were, therefore, induced with a spontaneous IgM-secreting myeloma (MTSB) obtained from an elderly BALB/c mouse. These cells secrete IgMK . Myeloma cells were grown in the peritoneal cavity of Pristane-primed BALB/c mice for the generation of ascites. Although the myeloma cells might secrete soluble IL4BPs, the bulk of the 11,01s in ascitic fluid probably comes from serum since the concentration of IIr4BPs in serum is 50% as high as that in ascites. IL4BPs were purified from pooled murine ascitic fluid by affinity chromatography on an 11,4-Affigel-10 column followed by removal of contaminating proteins by hydroxyapatite chromatography. Briefly, 500 ml ofpooled murine ascitic fluid, was centrifuged and delipidated using 1,1,2-trichloro-trifluorethane (0 .7 v/v) and was passed over an 11,4-Affigel-10 column, previously prepared by
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Soluble Interleukin 4 Receptors coupling 50 Ftg of rIL4 to 0.5 ml Affigel-10 following the manufacturer's instructions. After extensive washing with ice-cold PBS, the bound material was eluted with 6 M deionized urea in 0.1 M Tris-HCl buffer, pH 8.0 . The eluates were pooled, concentrated and equilibrated against 7.5 mM phosphate buffer, pH 7.2 using Amicon Centricon-10 devices (MW cut-off of 10 kD). The concentrated IIABPs preparations were further purified by incubation with hydroxyapatite equilibrated in 7.5 mM phosphate buffer, pH 7.2 . Greater than 90% of the IL4 binding activity remained in the supernatant while most of the contaminating proteins were removed. This method resulted in a >105-fold increase in specific activity (binding activity/protein) over that of the starting material . As previously reported using a different purification protocol (15) , all of the renatured IIr4-binding activity recovered after SDS-PAGE was associated with molecules in the range of 30-40 kD. Iodination ofrIL4, Recombinant Soluble IL4R and IL4BPs. rIL4 was iodinated using Iodogen (Pierce Chemicals, Rockford, IL)-coated tubes and repurified over an 11B11-Sepharose column, as described by Lowenthal, et al . (23) . The concentration of the labeled 1Ir4 preparation was determined based on its biologic activity in the HT-2 proliferation assay (24) and comparison with an unlabeled rIIr4 standard . The final 121 1-IIA preparation had a specific activity of 2 x 106 cpm/pmol . Recombinant soluble IIr4Rs or purified IL4BPs were iodinated using the lodogen method and were then centrifuged through Sephadex G-25 minicolumns in order to remove free iodine . For the one-dimensional peptide maps, the iodinated IIABPs preparation was further purified by preparative SDS-PAGE and elution of the 30-40 kD band .
One-Dimensional Aptide (Cleveland) Maps. One-dimensional peptide maps of iodinated soluble rIIAR and purified IL4BPs were carried out following the procedure described by Cleveland, et al . (25) . Briefly, aliquots of iodinated, soluble r1Ir4Rs or IIABPs (2-5 x 101 cpm) in 45 ld of PBS-0.2% SDS containing 0.5 mg/ml BSA as carrier protein, were incubated for 15 min at 37°C in the presence or absence of staphylococcal V8 protease (3 I~g) or immobilized trypsin (1 ug). Reactions were stopped by the addition of 50 Al of 2x Laemmli sample buffer (26) containing 5% 2-ME and boiling for 3 min. Samples were then subjected to SDS-PAGE on 15% polyacrylamide gels followed by exposure to Kodak XAR 2 films (Kodak, Rochester, NY) for 2-5 d at -70°C.
Measurement of ' 251-IL4 Binding to Cells and to Soluble IL4BPs. Binding of '25 1-IL4 to HT-2 cells was measured after incubation at 4°C and centrifugation through a dibutyl/dioctyl phthalate oil mixture, as described (24) . HT-2 cells possess a single class of high affinity 11,4-binding sites with a dissociation constant (Kd) of 5 x 10 -11 M (23, 27, 28) . Binding of '25 1-IL4 to soluble IIr4BPs in ascites or purified preparations was measured using centrifugation through Sephadex G-50 minicolumns, in order to separate free from bound 121 1-11,4 (15) . Briefly, samples were incubated with 1211-11,4 (at 2 x 10 -1°M) for 45 min at 4°C or 37°C, loaded onto 1 ml syringes containing Sephadex G-50 and centrifuged for 60 s at 600 g. Bound 12 '1-IL4 was excluded while free 1211-IL4 was retained inside the column . In both cellular and soluble binding assays, specific 121 1-IL4 binding was calculated by subtracting non-specific binding (cpm bound in the presence of a 100-fold molar excess of unlabeled IL4) from total binding (cpm bound in the absence of unlabeled IL4) .
Kinetic Binding Studies . (A) Dissociation experiments: To study the dissociation of bound 1211-IL4 from membrane I1ARs on HT-2 cells or from soluble IIr4BPs, cells or purified IL4BP preparations were incubated with 1211-IL4 (100 pM) in RPMI-1640 containing 5% FCS for 60 min at 4°C or 37°C . At 0 time, a 100-fold molar excess of unlabeled 11,4 (equilibrated to the same temperature) was added and the mixtures were incubated at 4°C or 37°C.
At intervals thereafter, 100 wl aliquots (containing 1( 6 cells or a constant amount ofIL4BPs) were centrifuged through a dibutyl/dioctyl phthalate oil mixture (HT-2 cells) or Sephadex G-50 minicolumns (soluble IL4BPs) and the remaining associated radioactivity (bound "1-IL4) was measured . Dissociation rate constants (k2) for both membrane and soluble IL4Rs were calculated using plots of (C) Dissociation rate constants : Dissociation constants (Kd) based on kinetic binding data for membrane IL4Rs on HT-2 cells and soluble IIL4BPs were calculated as the ratio of the dissociation rate constant to the association rate constant, i .e., Kd = k2/k1 .
Protection of 'zsl-IL4 from Proteolysis by IL4BPs. Constant amounts of 1211-IL4 (5 x 10^cpm) in 50 u1 of PBS containing 1 mg/ml BSA as carrier protein, were incubated at 4°C or 37°C with 1 or 0.3 Fcg of immobilized trypsin in the presence or absence of enough purified II,4BPs to bind >95% of the 1211-IL4 as determined by the soluble binding assay. After 15 min, 50 Al of 2x Laemmli sample buffer containing 5% 2-ME was added to each tube and the mixtures were placed in a boiling water bath for 3 min. The extent of proteolysis was then analyzed semi-quantitatively by SDS-PAGE in a 15% polyacrylamide gel followed by autoradiography.
Results
Purification of IL4BPs from Murine Ascitic Fluid. IL4BPs were purified from pooled mouse ascitic fluid by affinity chromatography on a rIL4-Affigel-10 column followed by removal of contaminating proteins by hydroxyapatite chromatography. This method resulted in a >105-fold increase in specific activity (binding activity/protein concentration) and an approximate recovery of 15-20% . After SDS-PAGE, the IL4-binding activity was associated with a relatively broad band of 30-40 kD (Fig. 1 A) . The broad band may be due to heterogeneity in glycosylation or the existence of multiple forms of IL4BPs . The IL4BPs purified by affinity chromatography were identical to the IL4BPs prepared using a previously published protocol (15) involving a combination of gel filtration, Blue-Sepharose affinity chromatography, chromatofocusing and hydrophobic chromatography. The 11,4-binding activity of such preparations could be completely removed by passage through an IL4Affigel-10 column.
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Structural and Immunologic Similarities between sIL4R and IL4BPs. Because IL4BPs and soluble rIIr4Rs have similar mol wt and affinities for RA, IL4BPs might be natural, soluble forms of IL4Rs. To investigate this possibility, one-dimensional (Cleveland) peptide maps (25) obtained after V8 protease or trypsin digestion of both iodinated soluble, rIL4Rs and purified IL4BPs, were compared. As shown in Fig. 1 B, proteolysis with either enzyme generated similar tyrosinecontaining peptide maps from both soluble rIL4Rs and purified IL4BPs . Since similar peptide patterns suggest similarities in the primary structure of proteins, these results indicate that the IL4BPs purified from ascitic fluid are structurally related to IL4Rs and suggest that IL4BPs might be the naturally-occurring forms of soluble IL4Rs. This interpretation was supported by evidence that a monoclonal rat antimurine IL4R antibody, which reacts with both membrane and soluble IL4Rs (21), but not normal rat IgG, immunoprecipitated IL4BPs (Fig. 1 A) and completely inhibited the IL4-binding activity of purified IL4BP preparations (Fig. 2) .
Inhibition of Binding of 125 1-IL4 to Cells at 4 and 37°C. In previous experiments we observed that low concentrations of M4BPs were very effective in blocking the binding of 125 1-IL4 to T or B cells at 4°C, but that the amounts needed to block the biological activity of 1174 on the same cells (incubated at 37°C) were substantially higher than those required for inhibition of binding (15) . Therefore, we determined whether the IL4BPs were equally effective at blocking binding of 125 1-IL4 to cells at 37°C. HT-2 cells (106 cells/tube) were incubated for 45 min at 4°C or 37°C with two different amounts of 125 1-IL4 (10 and 50 pM) in the presence or absence of varying concentrations of purified IL 4BPs. The amount of cell-bound IL4 was then determined . As shown in Fig . 3 , some inhibition of binding of 125 1-IL4 was observed at 37°C . However, the IL4BPs competed much less effectively for binding of IL4 to HT-2 cells at this temperature than at 4°C . The relatively poor ability of the IL 4BPs to compete for binding at the higher temperature was not due to an effect of receptor internalization at 37°C, since identical results were obtained if assays were carried out in the presence of 10 mM sodium azide and 2 mM 2-deoxyglucose in order to prevent receptor internalization . Similarly, potential inactivation of the IL4BPs at 37°C was excluded, since we could demonstrate binding of 121 1-IL-4 by the IL4BPs at 37°C in the soluble-phase binding assay and IL4BP preparations pre-incubated at either 4°C or 37°C for 60 min were equally effective at inhibiting binding of 125 I-11A to cells when tested at 4°C (results not shown) .
Affinity of IL4BPsfor 11,4 at 4°and 37°C. To determine whether the differences in the inhibitory ability of IL4BPs at 37°C were due to a temperature-induced decrease in the binding affinity and/or in the number of IL-4-binding sites, we performed Scatchard analyses (29) of equilibrium binding of 125 1-IL4 to soluble IL4BPs at 4°C and 37°C. In accord with previous findings, Scatchard analysis of the binding data at 4°C indicated the existence of a single class of high-affinity binding sites (Kd: 6 x 10' 11 M). Although a linear curve . was also obtained in the Scatchard plot at 37°C, a different After 45 mins at 4°C, specific binding was measured using a soluble phase binding assay as described . Results are expressed as percent of a control containing I ,4BPs in the absence of antibodies (control: 2,500 ± 150 cpm) . slope suggested a threefold decrease in affinity (Kd : 2 x 10 -'°M) . A similar intercept of the y-axis by both curves indicated virtually identical numbers of binding sites, arguing against either a potential inactivation of the IIJ4BPs or a reduction in the number of IL-4-binding sites (Fig. 4) . The threefold reduction in the Kd of the IL4BPs at 37°C was completely reversible if the cells were cooled to 4°C. Indeed, preparations that were pre-exposed at 37°C for 60 min had scribed. Resulting peptides patterns were compared after SDS-PAGE (15% gel) and autoradiography. Lanes 1, 3, and 5 : soluble rIL4R; lanes 2, 4, and 6 : purified IIr4BPs ; samples in lanes 1 and 2 were undigested, samples in lanes 3 and 4 were digested with V8 protease, and those in lanes 5 and 6 were digested with trypsin . Kd values at 4°C that were identical to those obtained for preparations maintained at 4°C. These results suggested that a potential temperature-induced change in conformation might have altered the binding characteristics of the IL4BPs.
Kinetic Binding Studies. Although, as determined by equilibrium binding studies (30) (31) (32) , the affinities of the p75 and p55 subunits of the IL2R differ by only 10-fold, kinetic binding measurements for 11,2 have revealed very significant differences in the manner in which the two different subunits bind 11,2 (33, 34) . Whereas the p75 (intermediate affinity) subunit has very slow association and dissociation rates, the p55 (low affinity) subunit has very rapid association/dissociation rates . The high-affinity IL2R (p75/p55) combines the fast association of p55 and the slow dissociation of p75 (33, 34) . By analogy, even though equilibrium binding analyses indicated that the IL4BPs and membrane IL4Rs have similar Kds, we determined whether potential differences in association/dissociation kinetics between soluble and membrane IL 4Rs at 4°C and 37°C, might explain the relatively lower inhibition by the IL4BPs at 37°C .
Kinetic association and dissociation rates were thus calculated for both the soluble IL4BPs (soluble-phase binding assay) and for membrane IL4Rs (using HT-2 cells) at both temperatures. As shown in Fig . 5 , dissociation of 114 from either the IL4BPs or membrane IL4Rs at 4°C was relatively slow, with t1i2 values of -112 and -180 min, respectively. At 37°C, however, the dissociation of 114 from soluble IL4BPs differed significantly from that of membrane I1,4Rs : the t1/2 for the IL4BPs was only -2 min, whereas that of membrane IL4Rs was -69 min . Although association rates were relatively fast for both soluble and membrane IL4Rs, rates were faster for the IL4BPs. Association and dissociation plots ( binding studies for both soluble and membrane IL4Rs. Moreover, Kd values for soluble IL4BPs obtained from kinetic data, showed a six-eight-fold higher dissociation constant at 37°C, reflecting the significantly faster dissociation rate of IL4BPs at this temperature. Thus, the faster dissociation rate and lower affinity of soluble IL4BPs at 37°C or 4°C might explain the differences in inhibition of binding at the two different temperatures . Two-step Incubation of 125 1--IL4 with IL4BPs and HT-2 Cells. The different kinetic binding properties of soluble IL 4BPs and membrane IL4Rs at 37°C have important implications for the potential physiological role of soluble IL4BPs in vivo. Because of the fast association/dissociation rates of 114 from soluble IL4BPs at 37°C, IL4/IL4BP complexes in vivo must be constantly dissociating and re-forming. In other words they would be transient and reversible, thereby allowing the ligand (IL4) to dissociate from one soluble IL 4BP molecule, and become available for binding to another IL4BP molecule or alternatively, to a membrane 114R. The slower dissociation kinetics of membrane IL4Rs, combined Protection ofH,4 from Proteolysis by IL4BPs. The fact that IL4 is able to rapidly bind to and dissociate from the IL4BPs at 37°C, thus becoming available to bind to membrane IL 4Rs, raises the possibility that IL4 might use IL4BPs as "carrier 3, 5 , 7, 9, and 11) of a two-fold molar excess of purified IIr4BPs in 50 p.l of PBS containing 1 mg/ml BSA. After 15 min at 37°C, 21°C or 4°C, 50 Ftl of SDS-PAGE sample buffer was added and the mixtures were incubated for 3 min in a boiling water bath . Digestion of the samples was estimatedby analysis using SDS-PAGE (15% gel) and autoradiography. Lanes 1 and 2: undigested; lanes 3-6, digested with 1 gg (3-4) or 0.3 hg trypsin (5 and 6) at 37°C; lanes 7, 8 digested with 1 P,g trypsin at 4°C; and lanes 9-12, digested with 1 Fig  (9 and 10 Fig . 7 , incubation of IL-4 with IL4BPs in BSA and in the absence of trypsin did not result in degradation or alteration of the mobility of IL4. When trypsin was added, the IL4BPs partially protected IL-4 from proteolytic degradation at all temperatures tested, although this effect was more pronounced at 4°C than at 37°C . This might reflect the faster dissociation of IL4 from the IL4BPs at higher temperatures, allowing more 11,4 to be exposed to the protease. Nonetheless, even at 37°C there was a significative difference in the extent of degradation of IL4 in the presence or absence of the IL4BPs. The decreased degradation of IL-4 in the presence of the IL 4BPs was due to a decreased susceptibility of IL4/IL4BPs complexes to enzymatic attack and not to an inhibitory effect on trypsin itself, since the hydrolysis of a chromogenic substrate for trypsin (N-benzoyl-Larginine ethyl ester) was unaffected by the addition of IL4BPs (data not shown) .
Discussion
Three major findings have emerged from these studies : (a) soluble IL4BPs in mouse sera and ascites are structurally and antigenically similar to soluble rIL4Rs; (b) the binding properties of the IL4BPs/sIL4Rs are consistent with a potential role as carrier proteins for IL-4 in vivo . In this regard, the dissociation of IL-4 from sIL4Rs is rapid, whereas dissociation of IL-4 from membrane IL4Rs is slow, suggesting that, at 37°C, IL-4 is not effectively sequestered from membrane IL4Rs even when bound to soluble IL4Rs (at the concentrations normally present in serum) ; (c) 114 is partially protected from enzymatic degradation following its binding to soluble IL4BPs.
Several lines of evidence suggest that the IL4BPs present in murine ascites are naturally-occurring forms of soluble IL 4Rs. Hence, Mosley, et al . (9) have reported that cDNAs encoding truncated, soluble forms of the murine IL4Rs (sIL 4R) are expressed in several types of murine cells and Fanslow, et al. (36) have recently reported the presence of molecules in mouse serum and ascitic fluid that react with monoclonal anti-IL-4R antibodies . Since the IL4BPs and sIL4Rs have similar binding affinities for IL-4 (Kds : N5 x 10 -11 M) (9, 15), similar molecular weights (9, 15), and can competitively inhibit the binding and the biologic activity of 114 (9, 15, 22) , the IL4BPs are most likely natural forms of soluble IL 4Rs. The present data support this contention based on similar peptide maps generated after proteolytic digestion as well as antigenic cross-reactivity. Whether or not the soluble IL 679 Fernandez-Botran et al .
4BPs originate from an alternatively-spliced mRNA encoding soluble IIr4Rs, or from proteolytic cleavage of membrane IL4Rs remains to be determined. Indeed, both mechanisms might contribute to the presence of IL4BPs in biological fluids. Based on the fact that the cDNA clones that encode soluble IIr4Rs contain a 114 by insertion that results in the addition of six new amino acid residues at the C-terminus (9), it should be possible to distinguish soluble IL-4R molecules generated by alternative mRNA splicing from those shed as a result of proteolytic cleavage by comparison of their C-terminal amino acid sequences . Regardless of the mechanism involved in their generation, it will be important to determine what cell types release sIL4Rs, the signals involved in this process and the factors regulating their generation. An obvious question regarding the presence of soluble IL 4Rs in biological fluids is whether they are involved in the regulation of IL4 activity in vivo. Based on evidence indicating that either purified IL4BPs or soluble rIIr4Rs interfere with the binding and activity of 114, we initially suggested that soluble IL4Rs might act in vivo by competing with cellular IL4Rs for the binding of free IL-4 in the circulation (15) . Unexpectedly, results of the present studies indicate that IL4BPs, at concentrations normally found in serum, (-20 ng/ml based on IL-4 binding activity) are not very effective competitors of membrane IL4Rs at physiological temperatures and that their properties are more consistent with a potential role as "carrier proteins" for IL-4 in vivo.
A comparison of the kinetics of IL4-binding to soluble and membrane IL4Rs at 4°C and 37°C, disclosed an important difference between both IL4Rs forms . Thus, dissociation of IL-4 from soluble and membrane IL4Rs was relatively slow at 4°C, whereas dissociation of IL-4 from soluble IL 4BPs followed significantly faster kinetics than that from membrane IL4Rs at 37°C. Since dissociation of 125 1-IL4 was measured after the addition of a 100-fold excess of unlabeled IL4, the possibility existed that the apparent increase in dissociation rate could be accounted for by negative-cooperativity' among soluble IL4Rs at 37°C . However, the fact that Scatchard curves for the binding of 125 1-IL4 to sIL4Rs at 37°C were not curvilinear argues against this possibility.
The molecular mechanisms responsible for the difference between the dissociation rates of soluble and membrane IL 4Rs are not clear. It is possible that increased temperature and/or ligand binding induce conformational changes in the soluble IL4BPs that result in the accelerated dissociation rate. These changes may not be induced in the membrane IL4Rs because of stability conferred by anchoring in the membrane through transmembrane and intracytoplasmic domains and/or association with other membrane protein(s) .
Because of the fast dissociation rate at 37°C, IL4 molecules would be constantly associating and dissociating from sIL4R molecules, thereby increasing their chance of binding to membrane IL4Rs . However, the equilibrium of 11,4 between both receptor forms would remain dependent upon the relative concentrations of soluble vs. membrane IL4Rs at any given anatomical site. Since 114 bound to soluble IL 4BPs can dissociate and bind to membrane IL4Rs, this suggests that even though most of the IL-4 in the circulation might be bound to soluble IL4BPs, it would still be available for binding to membrane IL4Rs, especially at those anatomical sites with high concentrations of IL-4R' cells (i.e., increased ratio of membrane IL4Rs to sIL4Rs) . In the circulation or in nonlymphoid tissues, the lower ratio of membrane to soluble IIT4Rs would favor binding to soluble IL4Rs . This could be a mechanism whereby active IL4 is preferentially delivered to lymphoid organs such as lymph nodes, spleen, thymus, etc ., while preventing its binding to cells at other sites. In addition, activated cells in distal sites expressing high densities of IL4Rs would have an advantage in capturing circulating IL4 carried by soluble IL4Rs. Such cells could thereby utilize the 11,4 produced at distant sites . Consistent with this possibility is the observation that the binding of IL4 by IL 4BPs protects IL-4 from proteolytic inactivation; it might also prolong the half-life of IL4 in the circulation by preventing its clearance . These possibilities could provide a mechanism for amplifying an immune response.
One implication of the above model is that pathological conditions that result in alterations in the normal levels of soluble IL4Rs, might lead to overall increased or decreased IL4 activity by altering the sIL4Rs/mIL4Rs ratio. Hence, it will be important to correlate the changes in the serum levels of soluble IL4Rs with the changes in the immune system observed in a variety of infectious diseases, immunodeficiencies, autoimmune and malignant diseases .
In addition to the potential role for soluble IL4Rs in the regulation of 11,4 activity under normal and pathological conditions, soluble IL4Rs and other soluble cytokine receptors, are also very attractive candidates for immunotherapy (37) . In this regard, recombinant soluble IL4Rs (if given in sufficiently high pharmacological concentrations) could be employed to selectively block IL-4 activity in vivo. This could be important in the treatment of allergic conditions. Therapy with soluble rIL4Rs would have some important advantages over immunotherapy with agents such as anti-cytokine or anti-cytokine receptor antibodies . Thus, the elicitation of an antibody response against the soluble IL4Rs would be unlikely. In addition, their smaller size might facilitate extravasation and/or penetration of tissues.
